SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
Metadatos
Mostrar el registro completo del ítemEditorial
Springer
Materia
Advanced breast cancer ABC Guidelines Endocrine therapy Anti-HER2 therapy IOT ADC
Fecha
2023-05-06Referencia bibliográfica
Garcia-Saenz, J.A., Blancas, I., Echavarria, I. et al. SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022). Clin Transl Oncol (2023). [https://doi.org/10.1007/s12094-023-03203-8]
Resumen
Advanced breast cancer represents a challenge for patients and for physicians due its dynamic genomic changes yielding to a resistance to treatments. The main goal is to improve quality of live and survival of the patients through the most appropriate subsequent therapies based on the knowledge of the natural history of the disease. In these guidelines, we summarize current evidence and available therapies for the medical management of advanced breast cancer.